Jump to content

Acalabrutinib: Revision history


For any version listed below, click on its date to view it. For more help, see Help:Page history and Help:Edit summary. (cur) = difference from current version, (prev) = difference from preceding version, m = minor edit, → = section edit, ← = automatic edit summary

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

31 August 2024

19 August 2024

18 July 2024

1 July 2024

10 March 2024

23 February 2024

20 December 2023

30 November 2023

17 September 2023

22 July 2023

19 July 2023

13 May 2023

5 March 2023

1 June 2022

31 May 2022

11 April 2022

8 March 2022

29 December 2021

2 November 2021

1 September 2021

  • curprev 07:0707:07, 1 September 2021 173.88.56.30 talk 14,491 bytes −77 Acalabrutinib has been shown to improve both induce remissions and increase remission duration, particularly when given with obinutuzumab. This was noted on 2021 clinical trials. undo Tags: Mobile edit Mobile web edit

22 March 2021

6 January 2021

17 November 2020

12 November 2020

19 October 2020

4 October 2020

23 August 2020

10 August 2020

29 July 2020

9 May 2020

30 April 2020

29 April 2020

19 April 2020

16 April 2020

15 April 2020

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)